Cargando…

ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year Results

PURPOSE: To report the 60-month safety and effectiveness results of a multicenter, prospective, randomized controlled trial comparing the ZILVER PTX paclitaxel-eluting stent to prosthetic above-the-knee bypass for the treatment of symptomatic TransAtlantic Inter-Society Consensus (TASC) C and D femo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosiers, Michel J., De Donato, Gianmarco, Torsello, Giovanni, Silveira, Pierre Galvagni, Scheinert, Dierk, Veroux, Pierfrancesco, Hendriks, Jeroen, Maene, Lieven, Keirse, Koen, Navarro, Tulio, Eckstein, Hans-Henning, Teβarek, Jörg, Giaquinta, Alessia, van den Eynde, Wouter, Verbist, Jürgen, Callaert, Joren, Deloose, Koen, Bosiers, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547807/ https://www.ncbi.nlm.nih.gov/pubmed/37670198 http://dx.doi.org/10.1007/s00270-023-03549-0

Ejemplares similares

Drug-eluting stents in the management of peripheral arterial disease
por: Bosiers, Marc, et al.
Publicado: (2008)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
por: Dake, Michael D., et al.
Publicado: (2019)

Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS
por: Dake, Michael D., et al.
Publicado: (2019)

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
por: Kichikawa, Kimihiko, et al.
Publicado: (2018)

AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
por: Bosiers, Marc, et al.
Publicado: (2009)

Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan
por: Ogawa, Yukihisa, et al.
Publicado: (2017)

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
por: Zeller, Thomas, et al.
Publicado: (2014)

First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study
por: Ye, Wei, et al.
Publicado: (2022)

AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
por: Bosiers, Marc
Publicado: (2008)

One-Year Results From the SURPASS Observational Registry of the CTAG Stent-Graft With the Active Control System
por: Torsello, Giovanni Federico, et al.
Publicado: (2020)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

Popliteal Artery Entrapment Syndrome: A Rare Cause of Interwoven Nitinol Stent Fracture After Femoropopliteal Interventions
por: Wittig, Tim, et al.
Publicado: (2022)

Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study
por: Reijnen, Michel M. P. J., et al.
Publicado: (2019)

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
por: Dake, Michael D., et al.
Publicado: (2020)

Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia
por: Groot Jebbink, Erik, et al.
Publicado: (2022)

24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent
por: Iida, Osamu, et al.
Publicado: (2021)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated Balloons
por: Piorkowski, Michael, et al.
Publicado: (2023)

Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020)

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
por: Laird, John A., et al.
Publicado: (2019)

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease
por: Stavroulakis, Konstantinos, et al.
Publicado: (2022)

Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
por: Teichgräber, Ulf, et al.
Publicado: (2022)

Endovascular assisted removal of intrapelvic lag screw after intramedullary proximal femoral nail: A case report and literature review
por: Mousati, Zakaria, et al.
Publicado: (2023)

A single stent strategy in patients with lifestyle limiting claudication: 3‐year results from the Durability II trial
por: Rocha‐Singh, Krishna J., et al.
Publicado: (2015)

Risk Factor Analysis for Crossing Failure in Primary Antegrade Wire-Catheter Approach for Femoropopliteal Chronic Total Occlusions
por: Bernardini, Giulia, et al.
Publicado: (2022)

Mini-invasive treatment of a large pseudoaneurysm of the neck related to central venous catheter placement: A case report
por: Palermo, Chiara, et al.
Publicado: (2018)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
por: De Pasquale, Concetta, et al.
Publicado: (2014)

Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis
por: Beggs, Clive B., et al.
Publicado: (2018)

An Intervention Study on the Implementation of Control Banding in Controlling Exposure to Hazardous Chemicals in Small and Medium-sized Enterprises
por: Terwoert, Jeroen, et al.
Publicado: (2016)

A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles
por: Cui, Fei, et al.
Publicado: (2013)

Transcriptional control by two interacting regulatory proteins: identification of the PtxS binding site at PtxR
por: Daddaoua, Abdelali, et al.
Publicado: (2013)

Penetrating aortic injury left untreated for 20 days: a case report
por: Giaquinta, Alessia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgvo3gebl2tjib8cm24uao2ckf